Munafa Stock Market Course + Intraday & FNO calls 
SPARC announcements Sun Pharma Advanced Research Company Limited announcements and dividends declared NSE
Sun Pharma Advanced Research Company Limited Complete list of announcements declared & dividend announcements by Sun Pharma Advanced Research Company Limited SPARC
Sun Pharma Advanced Research Company Limited SPARC listed on NSE and deals in PharmaceuticalsAnnouncements and dividends declared by Sun Pharma Advanced Research Company Limited SPARC
Sun Pharma-Organon deal: How a -billion merger will reshape India's pharma landscape
Sun Pharma is set to nearly double its revenue to billion with the acquisition of Organon, creating a global pharmaceutical giant. The deal leverages Organon's strengths in women's health, biosimilars, and established brands, aiming for significant gro
Announcement as on 28 April 2026
Sun Pharma shares rally 9% in two days after -bn Organon deal. Here's what Morgan Stanley, other brokerages say
Sun Pharmaceutical Industries' shares surged nearly 9% after announcing the .75 billion acquisition of Organon & Co., a global leader in women's health. The deal diversifies Sun Pharma's portfolio into women's health and biosimilars, with analysts f
Announcement as on 28 April 2026
Organon gives Sun Pharma scale and reach, but challenge lies in integration, execution
Sun Pharma has acquired Organon & Co for .75 billion. This deal provides Sun Pharma with expanded global scale and commercial reach. It also offers diversification into new segments like women's health and biosimilars. The acquisition is expected to
Announcement as on 28 April 2026
Sun Pharma to acquire Organon for .75 billion in India’s biggest pharma deal
Sun Pharma, led by Dilip Shanghvi, has agreed to acquire US-based Organon in an all-cash deal worth .75 billion, marking the largest acquisition ever by an Indian pharmaceutical company. The deal values Organon at per share and gives Sun Pharma a ma
Announcement as on 28 April 2026
Sun Pharma deal structurally strong, debt the only overhang: Amit Khurana
Market expert Amit Khurana offers insights on key corporate and regulatory developments. Sun Pharma's acquisition is seen as strategically sound, though debt requires careful management. Paytm Payments Bank's license cancellation has limited impact on its
Announcement as on 27 April 2026
Announcements by Sun Pharma Advanced Research Company Limited first page | Next page | Prev page |
SPARC Sun Pharma Advanced Research Company Limited current price & indicator signals
Recent prices of SPARC Sun Pharma Advanced Research Company Limited are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 15 Fri May 2026 | 163.65 | 162.56 to 172.19 | -3.78% | 0.19 times |
| 14 Thu May 2026 | 170.08 | 165.40 to 172.50 | 0.83% | 0.24 times |
| 13 Wed May 2026 | 168.68 | 165.00 to 175.60 | 1.35% | 0.49 times |
| 12 Tue May 2026 | 166.43 | 162.01 to 172.79 | -1.2% | 0.43 times |
| 11 Mon May 2026 | 168.45 | 167.00 to 172.79 | -2.68% | 0.36 times |
| 08 Fri May 2026 | 173.09 | 167.00 to 182.59 | 3.74% | 1.41 times |
| 07 Thu May 2026 | 166.85 | 155.37 to 168.80 | 6.22% | 1.17 times |
| 06 Wed May 2026 | 157.08 | 139.60 to 161.80 | 12.2% | 3.5 times |
| 05 Tue May 2026 | 140.00 | 139.32 to 145.01 | 0.21% | 0.51 times |
| 04 Mon May 2026 | 139.70 | 138.92 to 145.01 | -2.34% | 0.41 times |
| 30 Thu Apr 2026 | 143.04 | 141.51 to 163.20 | -3.72% | 1.48 times |
| 29 Wed Apr 2026 | 148.56 | 146.05 to 149.79 | 1.16% | 0.23 times |
Videos related to: SPARC announcements Sun Pharma Advanced Research Company Limited announcements and dividends declared NSE
Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra
Hindi Video What Is Needed To Succeed In Stock Markets
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance
